| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Travere Therapeutics, Inc. (TVTX) has 8 insiders with recent SEC Form 4 filings, including 1 buy and 14 sells. TVTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 432.9K | $23.29M | - | |
| Other | 138.6K | $7.46M | - | |
| Other | 123.1K | $6.62M | - | |
| CFO | 116.9K | $6.29M | - | |
| Other | 111.5K | $6.00M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2018 | Aselage Steve80 | Chief Executive Officer | Sell | 11,100 | $24.03 | $266,703.42 | -1.1% | |
| Nov 14, 2018 | McFarlane Neil F. | Chief Operating Officer | Sell | 10,000 | $23.73 | $237,314.40 | -14.7% | |
| Aug 31, 2018 | Aselage Steve80 | Chief Executive Officer | Sale+OE | 12,000 | $32.00 | $384,000.00 | -4.7% | |
| Feb 14, 2018 | Rote William E.58 | Senior Vice President, R&D | Sell | 1,034 | $21.50 | $22,232.03 | -8.5% | |
| Jan 5, 2018 | Reed Elizabeth E58 | SVP, GC &Corporate Secretary | Sell | 942 | $24.04 | $22,645.68 | -9.4% | |
| Aug 16, 2017 | McFarlane Neil F. | Chief Operating Officer | Sell | 1,378 | $22.50 | $31,005.00 | -9.2% | |
| Jun 14, 2017 | Aselage Steve80 | Chief Executive Officer | Buy | 5,000 | $17.85 | $89,250.00 | +2.1% | |
| Nov 22, 2016 | Aselage Steve80 | Chief Executive Officer | Sell | 8,200 | $21.12 | $173,160.00 | -1.7% | |
| Sep 1, 2016 | Shih Alvin | EVP Of Research &Development | Sell | 8,750 | $16.24 | $142,058.88 | -5.2% | |
| Jun 1, 2016 | Shih Alvin | EVP Of Research &Development | Sell | 8,750 | $17.75 | $155,283.63 | -5.0% |